Neurocrine Biosciences | Capitalizzazione Di Mercato



Market Capitalization Cambiamento Data
AbbVie USD 306.72B 7.3B 2025-04
Acadia Pharmaceuticals USD 2.46B 312M 2025-04
Agios Pharmaceuticals USD 1.57B 303M 2025-04
ALKERMES USD 4.4B 252M 2025-04
Alnylam Pharmaceuticals USD 29.63B 5.49B 2025-04
Amgen USD 155.38B 15.41B 2025-04
Biogen USD 17.08B 5.2B 2025-04
BioMarin Pharmaceutical USD 11.34B 1.19B 2025-04
Cytokinetics USD 4.49B 1.06B 2025-04
Dynavax Technologies USD 1.44B 237M 2025-04
Exelixis USD 10.33B 1000K 2025-04
Gilead Sciences USD 133.95B 18.86B 2025-04
Halozyme Therapeutics USD 7.56B 1.48B 2025-04
Incyte USD 13.05B 253M 2025-04
Ionis Pharmaceuticals USD 4.15B 1.37B 2025-04
Neurocrine Biosciences USD 9.87B 3.95B 2025-04
Pfizer USD 126.33B 24.01B 2025-04
Prothena USD 745M 155M 2024-12
Regeneron Pharmaceuticals USD 60.81B 8.53B 2025-04
Repligen USD 7.29B 139M 2025-04
Sarepta Therapeutics USD 5.03B 6.76B 2025-04
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 2.86B 1.03B 2025-04
Vertex Pharmaceuticals USD 127.19B 23.74B 2025-04



Neurocrine Biosciences Capitalizzazione Di Mercato - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.